Partnering Solutions

41. Rare Disease Center Of Excellence Overcomes Unique Obstacles 7/14/2022

    Biorasi’s Beeline platform provides clinical teams with unique, real-time transparency for quick responses to rare and urgent disease trial challenges.

42. Enabling Research At Speed And Scale For Maximal Impact 1/13/2026

    Our turnkey operational infrastructure empowers sponsors and partners to execute trials more efficiently — reducing costs, accelerating timelines, and consistently delivering high-quality data.

43. Avance Clinical's Specialist Areas Of Focus 8/8/2024

    Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.

44. Regulatory Consultancy Services 2/6/2025

    Global Strategies to Align Your Goals With Regulatory Requirements

    Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.

45. Greenphire Clinical Finance Suite: Budgeting Benchmarking 9/16/2025

    Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.

46. Clinical And Regulatory Strategy 11/7/2023

    Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.

47. Accelerating FIH Trials To POC With Speed, Safety, And Certainty 10/15/2025

    Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

48. Human ADME Studies: Human Metabolism Data For Regulatory Submission 10/16/2025

    Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.

49. The Global CRO For Biotechs 8/8/2024

    The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.

50. Comprehensive Services CNS Drug Development 4/9/2024

    Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.